descriptions of the intracranial virus injection surgery, including stereotaxic coordinates for 45 targeting injections to the dorsal cochlear nucleus and IC of mice, and how to combine whole cell 46 patch clamp recording with channelrhodopsin activation to investigate long-range projections to 47 IC neurons. Although this protocol is tailored to characterizing auditory inputs to the IC, it can be 48 easily adapted to investigate other long-range projections in the auditory brainstem and beyond. 49 50 INTRODUCTION: 51 52
Synaptic connections are critical to neural circuit function, but the precise topology and 53 physiology of synapses within neural circuits is often difficult to probe experimentally. This is 54 because electrical stimulation, the traditional tool of cellular electrophysiology, indiscriminately 55 activates axons near the stimulation site, and in most brain regions, axons from different sources 56 (local, ascending, and/or descending) intertwine. However, by using channelrhodopsin assisted 57 circuit mapping (CRACM) 1,2 , this limitation can now be overcome 3 . Channelrhodopsin (ChR2) is a 58 light activated, cation-selective ion channel originally found in the green alga Chlamydomonas 59
reinhardtii. ChR2 can be activated by blue light of a wavelength around 450-490 nm, depolarizing 60 the cell through cation influx. ChR2 was first described and expressed in Xenopus oocytes by 61 Nagel and colleagues 4 . Shortly after that, Boyden and colleagues 5 expressed ChR2 in mammalian 62 neurons and showed that they could use light pulses to reliably control spiking on a millisecond 63 timescale, inducing action potentials ~10 ms after activation of ChR2 with blue light. Optogenetic 64 channels with even faster kinetics have been found recently, e.g. Chronos 6 . 65 66
The basic approach to a CRACM experiment is to transfect a population of putative presynaptic 67 neurons with a recombinant adeno-associated virus (rAAV)-vector that carries the genetic 68 information for a channelrhodopsin. Transfection of neurons with rAAV leads to the expression 69 of the encoded channelrhodopsin. Typically, the channelrhodopsin is tagged with a fluorescent 70 protein like GFP (Green Fluorescent Protein) or tdTomato (red fluorescence), so that transfection 71 of neurons in the target region can easily be confirmed with fluorescence imaging. Because rAAVs 72 are non-pathogenic, have a low inflammatory potential and long lasting gene expression 7,8 , they 73
have become a standard technique to deliver channelrhodopsins to neurons. If, after transfection 74 of a putative presynaptic population of neurons, activation of a channelrhodopsin through light 75 flashes elicits postsynaptic potentials or currents in the target neurons, this is evidence of an 76 axonal connection from the transfected nucleus to the recorded cell. Because severed axons in 77
brain slice experiments can be driven to release neurotransmitter through channelrhodopsin 78 activation, nuclei that lie outside of the acute slice but send axons into the postsynaptic brain 79 region (the IC in our case) can be identified with CRACM. The power of this technique is that the 80 connectivity and physiology of identified long range synaptic inputs can be directly investigated. 81 82
In addition to channelrhodopsins that are excitable by blue light, investigators have recently 83
identified several red-shifted channelrhodopsins 9,10 , including Chrimson and its faster analog 84
ChrimsonR, both of which are excited with red light of ~660 nm 6 . targets, including the auditory thalamus and superior colliculus. We are now in a position to 105 determine the sources and function of local and long range inputs to VIP neurons and to 106 determine how these circuit connections contribute to sound processing. 107 108
The protocol presented here is tailored to investigating synaptic inputs to VIP neurons in the IC 109 of mice, specifically from the contralateral IC and the DCN (Fig. 1) . The protocol can be easily 110 adapted to different sources of input, a different neuron type or a different brain region 111
altogether. We also show that ChrimsonR is an effective red-shifted channelrhodopsin for long 112 range circuit mapping in the auditory brainstem. However, we demonstrate that ChrimsonR is 113 strongly activated by blue light, even at low intensities, and thus, to combine ChrimsonR with 114
Chronos Stereotaxic injection of AAV1.Syn.Chronos-GFP.WPRE.bGH into the right IC using coordinates 278
shown in Table 1 results in strong Chronos-GFP expression in the right IC (Figure 2A ). Visual 279 inspection of Chronos-GFP fluorescence indicates that most of the somata labeled in the right IC 280 are located in the central nucleus of the IC (ICc), but labeled somata are sometimes also present 281 in the dorsal cortex of the IC (ICd) and occasionally in the lateral cortex of the IC (IClc). The 282
targeting and extent of transfection should be checked for every animal used in an experiment, 283
as expression of channelrhodopsins in non-targeted regions can lead to false positives. To achieve 284 broader or more restricted expression of Chronos, the amount of deposited virus as well as the 285 stereotaxic coordinates can be easily adjusted to achieve the desired outcome. 286 287
Stereotaxic injection of AAV1.Syn.Chronos-GFP.WPRE.bGH in the DCN (see coordinates in Table  288 1) results in strong transfection of DCN neurons ( Figure 2B ). To confirm selective transfection of 289 the DCN, the brainstem of every animal should be sliced to verify that GFP expression was present 290 and limited to the DCN. If there is no transfection or if there is considerable expression of GFP in 291 the auditory nerve or VCN, recordings should not be performed. Using the coordinates shown in 292 Table 1 with a total injection volume of 40 nl, Chronos-GFP expression will be limited to the DCN 293 in most cases. GFP-labeled axons are present in the left (contralateral) ICc 3 weeks after injection 294
for both IC and DCN injection sites. 295 296
To test the long range trafficking of ChrimsonR, AAV1.Syn.ChrimsonR-tdTomato.WPRE.bGH was 297 injected into the right DCN, using the same coordinates as with Chronos injections. ChrimsonR 298 injection led to strong expression in the DCN, with tdTomato fluorescence visible in cells and 299 fibers ( Figure 3A ). In the contralateral ICc, fibers strongly labeled with tdTomato were clearly 300 visible after 3 weeks, demonstrating the long-range trafficking capability of the ChrimsonR-301 tdTomato construct when injected into auditory brainstem nuclei ( Figure 3B ). Optical activation 302
of ChrimsonR elicited EPSPs in IC VIP neurons ( Figure 5B ), indicating that ChrimsonR is a useful 303 tool for long-range CRACM experiments when the experimental parameters demand the use of 304 red light instead of blue light. However, we found that ChrimsonR was readily activated with blue 305 light, showing the same threshold for blue light activation as Chronos ( Figure 5 ). The sensitivity 306
of ChrimsonR to blue light means that special care must be taken to distinguish between inputs 307 transfected with ChrimsonR or Chronos in the same animal 13 . 308 309
When targeting recordings to VIP neurons in the contralateral (left) ICc after injections into the 310 right IC, blue light flashes elicited excitatory postsynaptic potentials (EPSPs) or inhibitory 311 postsynaptic potentials (IPSPs). This confirms commissural projections to VIP neurons. To analyze 312
commissural EPSPs and IPSPs separately, we used receptor antagonists to block IPSPs during EPSP 313 recordings, and vice versa. Representative EPSPs and IPSPs recorded during CRACM experiments 314 are shown in Figure 4 . IPSPs were observed in 6 out of 12 tested ICc VIP neurons. IPSPs were 315 small (1.53 mV ± 0.96 mV) and had moderate 10 -90% rise times (7.8 ms ± 2.1 ms), halfwidths 316
(15.1 ms ± 6.8 ms) and decay time constants (32.4 ms ± 17.0 ms) ( Figure 4A, left) . IPSPs were 317 completely abolished by the GABA A receptor antagonist gabazine (5 µM, Figure 4A , right; n = 6). 318
EPSPs were observed in 11 out of 27 ICc VIP neurons tested. EPSPs were also small (1.52 mV ± 319
1.08 mV) and had moderate 10 -90% rise times (8.3 ms ± 4.3 ms), halfwidths (19.6 ms ± 7.6 ms) 320
and decay time constants (43.5 ms ± 16.8 ms) ( Figure 4B "Control"). Adding the NMDA receptor 321 antagonist D-AP5 to the bath significantly reduced the halfwidth of EPSPs (14.3 ms ± 4.7 ms, p = 322 0.006) and revealed a trend toward reducing the rise time (6.3 ms ± 1.6 ms, p = 0.09) and decay 323 time constant (30.6 ms ± 7.3 ms, p = 0.06) of EPSPs (ANOVA for repeated measurements with 324
Tukey post-hoc test). The remainder of the EPSP was completely blocked by the AMPA receptor 325 antagonist NBQX ( Figure 4B "+ AP5 & NBQX" (scale bar shows 20 ms / 0.5 mV). Bottom: Relationship between optical power at 470 nm and 400 the probability of observing a ChrimsonR-driven PSP. Note that the threshold for blue light 401 activation of ChrimsonR PSPs was identical to the threshold for eliciting Chronos PSPs. 402 403 We have found that CRACM is a powerful technique for identifying and characterizing long range 408 synaptic inputs to neurons in the mouse IC. Following the protocol detailed here, we achieved 409 robust transfection of neurons in the DCN and IC as well as reliable axonal trafficking of Chronos 410
and ChrimsonR to synaptic terminals in the IC. Additionally, we demonstrated that this technique 411 enables the measurement and analysis of postsynaptic events, including PSP amplitude, 412 halfwidth, decay time, and receptor pharmacology. Our experience suggests that this approach 413 can be readily adapted to perform functional circuit mapping experiments throughout the 414 auditory brainstem and beyond. 415
